COVID-19

To break the cycle of recurrent Clostridioides difficile infection, physicians have shifted treatment strategies from antibiotics to fecal microbiota transplantation and live biotherapeutic products.

The FDA in 2023 approved treatments for several hospital-associated infections and fully approved a long-used COVID-19 medication, among other non-vaccine-related regulatory decisions.

On Dec. 14, the CDC issued an urgent warning calling for health care providers to increase vaccination coverage for COVID-19, influenza and respiratory syncytial virus.

The front page of Healio | Infectious Disease News this year included stories about COVID-19, new vaccines, reversing decades of ID dogma, and more.

As the COVID-19 pandemic enters its 5th year, its effect on children continues to be widely studied. We compiled a list of stories about pediatric COVID-19 that we reported over the course of the past year.

Mycophenolic acid, sirolimus and steroids were associated with an increased risk for COVID-19-related hospitalization among those who underwent kidney, liver, heart or lung transplant, data from JAMA Network Open showed.

To mark the end of 2023, we compiled a list of this year’s Pharmacology Consult columns, in which our contributing PharmDs dig deep into the newest research to report on emerging therapies and vaccines for infectious diseases.

Patients who died of a COVID-19 and tuberculosis coinfection had a shorter median time to death compared with patients who died of either COVID-19 or TB alone, according to results published in European Respiratory Journal.

Among patients with COVID-19, a low pectoralis muscle cross-sectional area on chest CTs appeared associated with heightened in-hospital mortality by day 30, according to results published in CHEST.

SAN DIEGO — COVID-19 vaccine boosters led to a significantly increased antibody response in patients using abatacept or TNF inhibitors regardless of whether they held medication, according to data presented at ACR Convergence 2023.